A comparative profitability analysis of transcatheter versus surgical aortic valve replacement in a high-volume French hospital.
François HuchetJacques Chan-PengFanny d'AcremontPatrice GuerinGael GrimandiJean-Christian RousselJulien PlessisVincent LetocartThomas SenageThibaut ManigoldPublished in: Health economics review (2019)
TAVR performed in carefully selected patients was associated with higher profits than SAVR, but also higher costs resulting in lower profitability.
Keyphrases
- aortic valve replacement
- aortic stenosis
- ejection fraction
- aortic valve
- end stage renal disease
- transcatheter aortic valve implantation
- transcatheter aortic valve replacement
- newly diagnosed
- chronic kidney disease
- healthcare
- prognostic factors
- heart failure
- peritoneal dialysis
- coronary artery disease
- patient reported outcomes
- acute care
- adverse drug